Decades of therapeutic and diagnostic improvements have provided considerable benefit to cancer patients battling their primary tumors.
Unfortunately, those battling relapse and metastasis have not benefited as much from these advancements and they now account for the vast majority of cancer-related deaths. To this day, there are limited treatment options in this setting.
At HiberCell, we are focused on developing novel ther...
Decades of therapeutic and diagnostic improvements have provided considerable benefit to cancer patients battling their primary tumors.
Unfortunately, those battling relapse and metastasis have not benefited as much from these advancements and they now account for the vast majority of cancer-related deaths. To this day, there are limited treatment options in this setting.
At HiberCell, we are focused on developing novel therapeutics to overcome foundational barriers that prevent patients from living longer, cancer-free lives.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.